BRPI0607043A2 - lacosamida para terapia de adição - Google Patents
lacosamida para terapia de adiçãoInfo
- Publication number
- BRPI0607043A2 BRPI0607043A2 BRPI0607043-4A BRPI0607043A BRPI0607043A2 BR PI0607043 A2 BRPI0607043 A2 BR PI0607043A2 BR PI0607043 A BRPI0607043 A BR PI0607043A BR PI0607043 A2 BRPI0607043 A2 BR PI0607043A2
- Authority
- BR
- Brazil
- Prior art keywords
- lacosamide
- addiction therapy
- therapy
- addiction
- addition therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
LACOSAMIDA PARA TERAPIA DE ADIçãO. A presente invenção refere-se ao uso de uma classe de compostos peptídicos para a prevenção, alívio e/ou tratamento de uma doença que seja tratada com antipsicóticos, em particular psicose, mais particularmente esquizofrenia,em uma terapia de adição a pelo menos um antipsicótico.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64741005P | 2005-01-28 | 2005-01-28 | |
EP05001843A EP1688137A1 (en) | 2005-01-28 | 2005-01-28 | SPM 927 for add-on therapy of schizophrenia |
PCT/EP2006/000722 WO2006079547A2 (en) | 2005-01-28 | 2006-01-27 | Spm 927 for add-on therapy of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0607043A2 true BRPI0607043A2 (pt) | 2009-08-04 |
Family
ID=36636204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607043-4A BRPI0607043A2 (pt) | 2005-01-28 | 2006-01-27 | lacosamida para terapia de adição |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1841417A2 (pt) |
JP (1) | JP2008528532A (pt) |
KR (1) | KR20070096058A (pt) |
AR (1) | AR057643A1 (pt) |
AU (1) | AU2006208630B2 (pt) |
BR (1) | BRPI0607043A2 (pt) |
CA (1) | CA2595330A1 (pt) |
EA (1) | EA015566B1 (pt) |
IL (1) | IL183973A0 (pt) |
MX (1) | MX2007009070A (pt) |
NO (1) | NO20074361L (pt) |
WO (1) | WO2006079547A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
TWI397417B (zh) * | 2006-06-15 | 2013-06-01 | Ucb Pharma Gmbh | 具有協同抗驚厥功效之醫藥組成物 |
EP2214657A1 (en) | 2007-10-23 | 2010-08-11 | UCB Pharma GmbH | Compounds for treating demyelination conditions |
WO2010077916A1 (en) * | 2008-12-16 | 2010-07-08 | Eurand, Inc. | Compositions comprising melperone |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
BR112013013525A2 (pt) | 2010-12-02 | 2016-10-18 | Ucb Pharma Gmbh | formulação de liberação controlada sólida de lacosamida para administração oral, composição farmacêutica sólida, e, método para a prevenção, alívio e/ou tratamento de uma doença do sistema nervoso central |
CN115813888A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
EP3558276A1 (en) | 2016-12-20 | 2019-10-30 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
WO2019113084A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
SG11202005016SA (en) | 2017-12-05 | 2020-06-29 | Sunovion Pharmaceuticals Inc | Nonracemic mixtures and uses thereof |
MX2020014286A (es) | 2018-06-20 | 2021-03-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina. |
KR20220018004A (ko) | 2019-06-04 | 2022-02-14 | 선오비온 파마슈티컬스 인코포레이티드 | 조절 방출 제형 및 이의 용도 |
US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5773475A (en) | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
DK1243262T3 (da) | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter |
EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
-
2006
- 2006-01-27 EA EA200701594A patent/EA015566B1/ru not_active IP Right Cessation
- 2006-01-27 MX MX2007009070A patent/MX2007009070A/es active IP Right Grant
- 2006-01-27 BR BRPI0607043-4A patent/BRPI0607043A2/pt not_active IP Right Cessation
- 2006-01-27 AR ARP060100304A patent/AR057643A1/es not_active Application Discontinuation
- 2006-01-27 CA CA002595330A patent/CA2595330A1/en not_active Abandoned
- 2006-01-27 EP EP06706448A patent/EP1841417A2/en not_active Withdrawn
- 2006-01-27 AU AU2006208630A patent/AU2006208630B2/en not_active Ceased
- 2006-01-27 WO PCT/EP2006/000722 patent/WO2006079547A2/en active Application Filing
- 2006-01-27 JP JP2007552583A patent/JP2008528532A/ja not_active Withdrawn
- 2006-01-27 KR KR1020077019581A patent/KR20070096058A/ko not_active Application Discontinuation
-
2007
- 2007-06-14 IL IL183973A patent/IL183973A0/en unknown
- 2007-08-27 NO NO20074361A patent/NO20074361L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2595330A1 (en) | 2006-08-03 |
AU2006208630A1 (en) | 2006-08-03 |
AR057643A1 (es) | 2007-12-12 |
AU2006208630B2 (en) | 2011-09-29 |
IL183973A0 (en) | 2008-12-29 |
KR20070096058A (ko) | 2007-10-01 |
NO20074361L (no) | 2007-10-26 |
WO2006079547A2 (en) | 2006-08-03 |
MX2007009070A (es) | 2007-09-12 |
EA200701594A1 (ru) | 2008-02-28 |
WO2006079547A3 (en) | 2006-09-21 |
EA015566B1 (ru) | 2011-10-31 |
EP1841417A2 (en) | 2007-10-10 |
JP2008528532A (ja) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607043A2 (pt) | lacosamida para terapia de adição | |
JO3235B1 (ar) | مركبات بيررولوبيريميدين و استعمالاتها | |
MX2009011127A (es) | Metodo de prevencion y tratamiento de angiopatia amiloide cerebral. | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
MY147247A (en) | Organic compounds and their uses | |
GEP20084520B (en) | Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases | |
BRPI0511995A (pt) | uso de compostos peptìdicos para tratamento de dor em neuralgia trigeminal | |
BRPI0410503B8 (pt) | composição tópica e uso da composição | |
MX2009009207A (es) | Metodos y composiciones para normalizar las secreciones de glandulas meibomianas. | |
CR20130455A (es) | Composiciones para el tratamiento de tumores | |
BRPI0508758A (pt) | processo para a preparação de cloridrato de oxicodona tendo menos que 25 ppm de 14 - hidroxicodeinona | |
BR0310092A (pt) | Combinação de compostos orgânicos | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
GT200600115A (es) | Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal | |
BRPI0510947A (pt) | tratamento de doença respiratória | |
BRPI0513317A (pt) | ciclosporinas para tratar doença de alzheimer | |
BRPI0715698B8 (pt) | produto, composição farmacêutica que o contém e uso de composto | |
WO2005118636A3 (en) | Tgf derepressors and uses related thereto | |
CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
TW200637538A (en) | Lacosamide for add-on-therapy | |
TNSN08496A1 (en) | Aminothiazoles and their uses | |
UY29417A1 (es) | Agentes endoparasiticidas | |
CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
BRPI0712561B8 (pt) | Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida | |
MA38369A1 (fr) | Peptides et compositions pour le traitement d'une lesion de l'articulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |